Product Program year 2021 Source: CMS Open Payments

Nephrocheck Test

Device Diagnostic

PDI B0745000110

Open in the dashboard

General payments

$139,577

42 payments

Research payments

$0

0 payments

Through program year 2021, $139,577 in general payments and $0 in research payments were reported against Nephrocheck Test (Diagnostic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $139,577 42

Breakdown

Who paid General payments · program year 2021
  1. Astute Medical, Inc. $101,976 19 payments
  2. bioMerieux $37,601 23 payments
Top recipients General payments · program year 2021
  1. Massachusetts General Hospital Teaching hospital · MA $50,000 36% · 1 payment
  2. John Kellum Pittsburgh, PA $35,534 25% · 14 payments
  3. Boston Medical Center Teaching hospital · MA $15,000 11% · 1 payment
  4. Steven Conrad Critical Care Medicine · Shreveport, LA $9,888 7% · 2 payments
  5. James Miner Emergency Medicine · Minneapolis, MN $9,441 7% · 3 payments

The top 5 of 19 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Critical Care Medicine Internal Medicine $9,948 25% · 2 practitioners
  2. Emergency Medicine $9,441 24% · 1 practitioner
  3. Critical Care Medicine Anesthesiology $9,144 23% · 2 practitioners
  4. Anesthesiology $8,498 22% · 1 practitioner
  5. Nephrology Internal Medicine $1,468 4% · 3 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Massachusetts $73,498 53% · 3 recipients
  2. Pennsylvania $35,622 26% · 2 recipients
  3. Louisiana $9,888 7% · 1 recipient
  4. Minnesota $9,441 7% · 1 recipient
  5. New York $9,105 7% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

42 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record